Morgan Stanley Downgrades Haemonetics to Equal-Weight, Lowers Price Target to $83
Morgan Stanley analyst Drew Ranieri downgrades Haemonetics (NYSE:HAE) from Overweight to Equal-Weight and lowers the price target from $147 to $83.
55 Biggest Movers From Yesterday
Gainers
Marlin Business Services Corp. (NASDAQ: MRLN) shares surged 50.7% to close at $21.46 on Monday after the company enters into a definitive agreement to be acquired by funds managed by HPS Investment Partners for $23.50 per share in cash.